NDAINTRAVENOUSPOWDERPriority Review
Approved
Aug 2014
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
4/8 — Partial
Priority Review
ORBACTIV (oritavancin) by CorMedix is cytochrome p450 2c19 inhibitors [moa]. First approved in 2014.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ORBACTIV (oritavancin) is a lipoglycopeptide antibacterial antibiotic administered intravenously as a powder for injection. It inhibits bacterial cell wall synthesis and possesses activity against gram-positive pathogens including methicillin-resistant Staphylococcus aureus (MRSA). The drug is indicated for acute bacterial skin and skin structure infections (ABSSSIs) in hospitalized patients.
$0.231MPart D
Peak9.2 years to LOEProduct is at peak commercial maturity with minimal Part D penetration (69 claims in 2023), indicating a niche positioning with limited team scaling opportunities.
Mechanism of Action
Cytochrome P450 2C19 Inhibitors
Pharmacologic Class:
Lipoglycopeptide Antibacterial
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
ORBACTIV currently supports minimal career opportunity with only 1 linked job posting, primarily in field training. The peak-stage product with niche market penetration (69 Part D claims) offers limited scope for commercial team expansion.
National Field Trainer
1 open roles linked to this drug
Worked on ORBACTIV at CorMedix? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.